Therefore, the above data suggest that the potent antisteatotic effects of krill oil supplementation in the livers of mice with diet-induced obesity and exacerbated hepatic steatosis are associated with improved whole-body and tissue sensitivity to insulin, but cannot be explained by changes in VLDL-TAG secretion. The gene discussed is INS; the disease is Hepatic steatosis.